Related references
Note: Only part of the references are listed.
Review
Public, Environmental & Occupational Health
Karen Bishop et al.
Summary: This review examines methods and practices related to analyzing multiple causes of death and finds a growing international interest in this area. Available methods are diverse and can be applied to various research objectives. With the advancement of data and technology, there is potential for further development and application of these methods in different settings.
Article
Oncology
Jingxuan Zhao et al.
Summary: This study examined changes in patterns of cancer-related deaths during the first year of the coronavirus disease 2019 (COVID-19) pandemic in the United States. The death rate with cancer as the underlying cause continued to decrease in 2020, while the death rate with cancer as a contributing cause increased. This trend may be associated with delays in cancer diagnosis and receipt of care during the pandemic.
JCO ONCOLOGY PRACTICE
(2023)
Article
Oncology
Changchuan Jiang et al.
Summary: The study found that cancer survivors are more likely to have multiple chronic conditions, which are more common in Black survivors and those with lower socioeconomic status. Therefore, it is important to strengthen protection for survivors in healthcare facilities and prioritize cancer patients and survivors in vaccine distribution.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2022)
Review
Medicine, General & Internal
Patrick Davey et al.
Summary: This review examines the association between androgen deprivation therapy (ADT) and cardiovascular risk in patients with prostate cancer. The current evidence suggests that GnRH antagonists may be associated with lower rates of certain cardiovascular events compared to agonists. Risk reduction strategies, such as lifestyle modifications and consideration of ADT modality, may help improve outcomes in prostate cancer patients.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
(2022)
Article
Endocrinology & Metabolism
Ugo Fedeli et al.
Summary: The aim of this study is to assess the role of diabetes as a cause of death during different epidemic waves of COVID-19. The study found that the COVID-19 pandemic interrupted the long-term declining trend in diabetes-related mortality, and diabetes and COVID-19 accounted for a significant proportion of excess deaths.
DIABETES RESEARCH AND CLINICAL PRACTICE
(2022)
Letter
Oncology
Xuesong Han et al.
Article
Oncology
Thomas Chatzikonstantinou et al.
Summary: Patients with CLL are more susceptible to the impact of COVID-19, with age, CLL-directed treatment, and cardiac failure being significant risk factors for outcomes. Untreated patients have a better chance of survival, and age, cardiac failure, and CLL-directed treatment are significant risk factors for OS.
Editorial Material
Medicine, General & Internal
Farida B. Ahmad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Article
Oncology
Souad Assaad et al.
Summary: COVID-19 poses a high risk of early mortality for cancer patients with solid or haematological tumors. Among COVID-19 positive cancer patients, the virus was reported as the cause of death in 50% of cases.
BRITISH JOURNAL OF CANCER
(2021)
Letter
Medicine, General & Internal
Steven H. Woolf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2020)
